During the past decade, Hospital Quiron Barcelona; Servicio de Oncologia conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Quiron Barcelona; Servicio de Oncologia" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "SOLTI Breast Cancer Research Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Quiron Barcelona; Servicio de Oncologia" #1 collaborator was "NSABP Foundation Inc" with 2 trials as a collaborator, "Alliance Foundation Trials, LLC." with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Quiron Barcelona; Servicio de Oncologia" are "Breast Cancer" (4 trials), "Metastatic Breast Cancer" (3 trials), "Breast Neoplasms" (1 trials), "HER2-Positive Primary Breast Cancer" (1 trials) and "Residual Invasive Breast Cancer" (1 trials). Many other conditions were trialed in "Hospital Quiron Barcelona; Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital Quiron Barcelona; Servicio de Oncologia" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (3 trials), "Paclitaxel" (3 trials), "Bevacizumab" (1 trials), "DS-8201a" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Quiron Barcelona; Servicio de Oncologia" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Quiron Barcelona; Servicio de Oncologia". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Quiron Barcelona; Servicio de Oncologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Quiron Barcelona; Servicio de Oncologia, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".